Plain-English translation of NCT06746233 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
When someone has a sudden heart attack caused by a blocked artery, doctors need to open that artery quickly. This trial is testing whether a special balloon coated with the drug paclitaxel works just as well as a stent (a small metal tube that stays in place) for opening the artery. Both treatments are used in emergency situations, but doctors want to know which one gives patients the best long-term results.
Stents have been the standard treatment for heart attacks for many years, but this medication-coated balloon is newer and might offer advantages like avoiding permanent metal implants in the heart. This trial will help doctors decide which treatment is safest and most effective for patients in this life-threatening situation.
You likely qualify if…
You likely don't qualify if…
If you qualify and agree to join, you'll be randomly assigned to receive one of the two treatments during your emergency heart attack procedure—either the medication-coated balloon or the stent. Your doctor will perform the procedure as part of your standard emergency care. After that, you'll be followed with regular appointments and tests to monitor your heart health and compare how well each treatment works over time.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
Bosnia and Herzegovina
Serbia